Q1 2017 Holdings
Filed 2017-05-15 | 47 holdings | $158.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Acadia Pharmaceuticals Inc(ACAD) | Common | 004225108 | $56.0M | 1,630,000 | 35.5% |
| Biomarin Pharmaceutical Inc(BMRN) | Common | 09061G101 | $51.8M | 590,000 | 32.8% |
| Ascendis Pharma(ASND) | Sponsored ADR | 04351P101 | $19.6M | 700,924 | 12.4% |
| Biocryst Pharmaceuticals Inc(BCRX) | Common | 09058V103 | $13.5M | 1,603,001 | 8.5% |
| Catalyst Pharmaceuticals Inc(CPRX) | Common | 14888U101 | $7.4M | 3,804,745 | 4.7% |
| Akebia Therapeutics Inc(AKBA) | Common | 00972D105 | $4.2M | 456,369 | 2.7% |
| Corvus Pharmaceuticals Inc(CRVS) | Common | 221015100 | $2.5M | 121,715 | 1.6% |
| Cellectis(CLLS) | Sponsored ADR | 15117K103 | $2.3M | 97,096 | 1.5% |
| Immunomedics Inc(IMMU) | Common | 452907108 | $67.9K | 10,488,076 | 0.0% |
| Tesaro Inc | Common | 881569107 | $63.4K | 411,823 | 0.0% |
| Medicines Co | Common | 584688105 | $57.9K | 1,185,000 | 0.0% |
| Dermira Inc(DERMEUR) | Common | 24983L104 | $41.0K | 1,202,313 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | Common | 03152W109 | $34.6K | 4,847,577 | 0.0% |
| Lion Biotechnologies Inc | Common | 53619R102 | $33.9K | 4,551,343 | 0.0% |
| Array Biopharma Inc(ARRYEUR) | Common | 04269X105 | $33.8K | 3,780,000 | 0.0% |
| Global Blood Therapeutics Inc | Common | 37890U108 | $30.0K | 815,000 | 0.0% |
| Teligent Inc | Common | 87960W104 | $29.6K | 3,791,512 | 0.0% |
| Seattle Genetics Inc | Common | 812578102 | $28.3K | 450,000 | 0.0% |
| Clovis Oncology Inc(CLVSEUR) | Common | 189464100 | $22.5K | 353,900 | 0.0% |
| Aerie Pharmaceuticals Inc(AERIEUR) | Common | 00771V108 | $19.3K | 425,000 | 0.0% |
| Pacira Pharmaceuticals Inc(PCRX) | Common | 695127100 | $18.7K | 410,000 | 0.0% |
| Assembly Biosciences Inc | Common | 045396108 | $17.8K | 696,409 | 0.0% |
| Avexis Inc | Common | 05366U100 | $17.1K | 225,370 | 0.0% |
| Neuroderm LTD | Common | M74231107 | $15.7K | 590,000 | 0.0% |
| Agenus Inc(AGENEUR) | Common | 00847G705 | $12.7K | 3,368,828 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | Common | 60468T105 | $12.4K | 2,383,201 | 0.0% |
| Vanda Pharmaceuticals Inc(VNDA) | Common | 921659108 | $8.6K | 617,200 | 0.0% |
| Veracyte Inc(VCYT) | Common | 92337F107 | $8.3K | 906,999 | 0.0% |
| Alimera Sciences Inc | Common | 016259103 | $8.1K | 5,791,581 | 0.0% |
| Cascadian Therapeutics Inc | Common | 14740B606 | $7.5K | 1,821,248 | 0.0% |
| Blueprint Medicines Corp(2L9) | Common | 09627Y109 | $6.6K | 165,000 | 0.0% |
| Axovant Sciences LTD | Common | G0750W104 | $5.7K | 384,587 | 0.0% |
| Viveve Medical Inc | Common | 92852W204 | $5.6K | 890,000 | 0.0% |
| Sorrento Therapeutics Inc(SRNE) | Common | 83587F202 | $4.7K | 1,192,130 | 0.0% |
| Fortress Biotech Inc | Common | 34960Q109 | $3.7K | 996,663 | 0.0% |
| Aveo Pharmaceuticals Inc(AVEOEUR) | Common | 053588109 | $2.3K | 3,938,030 | 0.0% |
| Oncobiologics Inc | Common | 68235M105 | $1.8K | 683,531 | 0.0% |
| Pernix Therapeutics Holdings Inc | Convertible Debt | 71426VAK4 | $1.7K | $6,000,000 | 0.0% |
| Bellicum Pharmaceuticals Inc | Common | 079481107 | $1.5K | 125,000 | 0.0% |
| Trillium Therapeutics Inc | Common | 89620X506 | $1.4K | 227,399 | 0.0% |
| Array Biopharma Inc(ARRYEUR)Call | Common | 04269X105 | $390 | 861,400 | 0.0% |
| Clovis Oncology Inc(CLVSEUR)Call | Common | 189464100 | $258 | 125,800 | 0.0% |
| Amicus Therapeutics Inc(FOLD)Call | Common | 03152W109 | $206 | 250,000 | 0.0% |
| Oncobiologics Inc - Warrant A | Warrant | 68235M113 | $187 | 233,333 | 0.0% |
| Oncobiologics Inc - Warrant B | Warrant | 68235M121 | $117 | 233,333 | 0.0% |